TrianglePUBLICATIONS · 11920506
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2002 Mar 1
- First author
- Cortes J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Cortes J
- type
- Author
- name
- Thomas D
- type
- Author
- name
- Rios A
- type
- Author
- name
- Koller C
- type
- Author
- name
- O'Brien S
- type
- Author
- name
- Jeha S
- type
- Author
- name
- Faderl S
- type
- Author
- name
- Kantarjian H
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Cortes J
- type
- Author
- name
- Thomas D
- type
- Author
- name
- Rios A
- type
- Author
- name
- Koller C
- type
- Author
- name
- O'Brien S
- type
- Author
- name
- Jeha S
- type
- Author
- name
- Faderl S
- type
- Author
- name
- Kantarjian H
- type
- Author
- bibliography ids
- nci-bib-91255cfff7ec797aec567426
- book metadata
- content sha256
- a0c7f56b3b23420ec47fe225e5bb8aa610f700771e498140b786a0da9932c40d
- document type
- citation
- dois
- 10.1002/cncr.10365
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11920506
- immutable id
- pubmed:11920506@a0c7f56b3b23420ec47fe225e5bb8aa610f700771e498140b786a0da9932c40d
- journal
- abbreviation
- Cancer
- issn electronic
- Source null
- issn print
- 0008-543X
- issue
- 5
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 1492-9
- volume
- 94
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11920506
- provenance
- batch id
- d4e82e28940c878dd0a2
- provider
- NCBI PubMed ESummary
- record sha256
- a61a3dcf76ff93f1a9a56f7bd7ee2a592669382ce120a3296a378b7753ec63ae
- response sha256
- 257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
- retrieved at
- 2026-09-09T23:45:44.017762+00:00
- publication date
- display
- 2002 Mar 1
- precision
- day
- year
- 2002
- publication types
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.
Preserved source evidence · Not medical advice